Skip to main content

Table 2 Distributions of the EORTC QLQ-C30 and QLQ-CR29 scores for Taiwanese colorectal cancer patients

From: Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients

Scale

N

Mean

Standard deviation

Minimum

Maximum

Reproducibility

QLQ-C30

 QL2(Q29-Q30)

102

63.9

21.3

0.0

100.0

0.82

 PF(Q1-Q5)

108

81.9

19.0

20.0

100.0

0.81

 RF(Q6-Q7)

107

79.6

25.6

0.0

100.0

0.84

 EF(Q21-Q24)

106

80.9

17.7

25.0

100.0

0.64

 CF(Q20,Q25)

106

79.7

18.0

33.3

100.0

0.48

 SF(Q26,Q27)

106

78.1

22.5

0.0

100.0

0.58

 FA(Q10,Q12,Q18)

107

30.4

20.2

0.0

88.9

0.72

 NV(Q14,Q15)

108

8.2

13.8

0.0

66.7

0.52

 PA(Q9,Q19)

108

17.1

17.6

0.0

83.3

0.11

 DY(Q8)

107

13.1

19.3

0.0

100.0

0.29

 SL(Q11)

106

24.5

26.5

0.0

100.0

0.74

 AP(Q13)

108

16.4

23.0

0.0

100.0

0.59

 CO(Q16)

107

24.3

26.1

0.0

100.0

0.56

 DI(Q17)

106

23.3

29.2

0.0

100.0

0.63

 FI(Q28)

106

15.1

23.5

0.0

100.0

0.47

QLQ-CR29

 BI(Q45-Q47)

105

86.7

19.2

0.0

100.0

0.89

 ANX(Q43)

105

62.9

24.2

0.0

100.0

0.47

 WEI(Q44)

105

74.6

24.3

0.0

100.0

0.48

 SEXF(Q56,Q58)

99

17.5

19.8

0.0

100.0

0.47

 UF(Q31,Q32)

105

21.6

21.4

0.0

100.0

0.51

 BMS(Q38,Q39)

104

11.7

19.1

0.0

100.0

0.34

 SF2(Q52,Q53)

99

20.7

20.8

0.0

83.3

0.78

 UI(Q33)

105

6.3

17.4

0.0

100.0

0.11

 DY2(Q34)

105

2.5

8.9

0.0

33.3

0.69

 AP2(Q35)

105

14.0

21.6

0.0

100.0

0.68

 BP(Q36)

103

10.0

17.4

0.0

66.7

0.71

 BF(Q37)

104

20.5

22.9

0.0

100.0

0.40

 DM(Q40)

105

28.9

20.2

0.0

100.0

0.09

 HL(Q41)

103

17.5

28.7

0.0

100.0

0.85

 TA(Q42)

104

11.2

21.6

0.0

100.0

0.67

 FL(Q49)

101

21.8

26.0

0.0

100.0

0.81

 FI2(Q50)

101

10.6

20.0

0.0

100.0

0.47

 SS(Q51)

98

8.2

16.6

0.0

66.7

0.63

 EMB(Q54)

100

13.7

24.2

0.0

100.0

0.50

 STO(Q55)

13

5.1

12.5

0.0

33.3

0.89

 IMP(Q57)

59

20.3

21.5

0.0

100.0

0.97

 DYS(Q59)

39

9.4

20.2

0.0

66.7

0.65

  1. QL2 global health/quality of life, PF physical function, RF role function, EF emotion function, CF cognitive function, SF social function, FA fatigue, NV nausea/vomiting, PA pain, DY dyspnea, SL insomnia, AP appetite loss, CO constipation, DI diarrhea, FI financial difficulty, BI body image, ANX anxiety, WEI weight, SEXF sexual interest, UF urinary frequency, BMS blood and mucus in stool, SF2 stool frequency, UI urinary incontinence, DY2 dysuria, AP2 abdominal pain, BP buttock pain, BF bloating, DM dry mouth, HL hair loss, TA taste, FL flatulence, FI2 faecal incontinence, SS sore skin, EMB embarrassment, STO stoma care problem, IMP importance, DYS dyspareunia